Valuation: Hologic, Inc.

Market Cap 16.97B 14.9B 13.86B 12.72B 23.9B 1,634B 24.27B 165B 64.3B 803B 63.7B 62.33B 2,778B P/E 2024
24.3x
P/E 2025 27x
Enterprise Value 17.39B 15.27B 14.2B 13.03B 24.49B 1,675B 24.87B 169B 65.9B 823B 65.28B 63.87B 2,847B EV / Sales 2024
4.74x
EV / Sales 2025 3.75x
Free-Float
73.08%
Yield 2024 *
-
Yield 2025 -
1 day+0.48%
6 months+1.28%
Current year+2.04%
Current year 74.49
Extreme 74.49
76.07
1 year 63.19
Extreme 63.1923
76.07
3 years 51.9
Extreme 51.9
84.67
5 years 51.9
Extreme 51.9
87.88
10 years 26.49
Extreme 26.49
87.88
Manager TitleAgeSince
Chief Executive Officer 63 07/04/2026
Director of Finance/CFO - 16/04/2026
Chief Operating Officer 46 01/01/2024
Director TitleAgeSince
Director/Board Member 63 07/04/2026
Date Insider Type Main position Quantity % Market Cap.
7/4/26 Issuer sale

Director

56,632 0.0254%
7/4/26 Issuer sale

Executive/Senior Manager

123,246 0.0552%
7/4/26 Issuer sale

Director

65,866 0.0295%
Change 5-day change 1-year change 3-year change Capi.($)
+0.48%-.--%+14.99%-6.53% 16.97B
-0.71%+6.72%+19.63%-0.57% 211B
-0.52%-6.05%-5.58%-25.77% 135B
+1.65%-2.29%-30.93%+4.31% 119B
+1.54%+0.50%-58.34%-15.18% 65.77B
-1.42%-3.62%+9.01%-9.60% 47.58B
+3.03%-0.17%-26.81%-31.58% 44.44B
-0.84%+5.41%+15.14%+8.50% 39.14B
-2.02%+1.54%+25.53%+30.56% 36.79B
-1.41%+3.99%+80.31%+3.20% 29.37B
Average -0.02%+0.49%+4.30%-4.27% 74.51B
Weighted average by Cap. +0.01%+0.37%-1.00%-6.03%

Financials

2024 2025
Net sales 4.03B 3.54B 3.29B 3.02B 5.68B 388B 5.76B 39.09B 15.27B 191B 15.13B 14.8B 660B 4.1B 3.6B 3.35B 3.07B 5.77B 395B 5.86B 39.77B 15.54B 194B 15.39B 15.06B 671B
Net income 790M 693M 645M 592M 1.11B 76.03B 1.13B 7.66B 2.99B 37.38B 2.96B 2.9B 129B 566M 497M 462M 424M 797M 54.48B 809M 5.49B 2.14B 26.78B 2.12B 2.08B 92.6B
Net Debt 321M 282M 262M 241M 452M 30.94B 459M 3.12B 1.22B 15.21B 1.21B 1.18B 52.6B 421M 370M 344M 315M 593M 40.53B 602M 4.08B 1.59B 19.93B 1.58B 1.55B 68.9B
Logo Hologic, Inc.
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Employees
7,070
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. HOLX Stock